[Case fatality of COVID-19 in patients with neurodegenerative dementia].
Neurologia 2020;
35:639-645. [PMID:
38620303 PMCID:
PMC7386259 DOI:
10.1016/j.nrl.2020.07.005]
[Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Revised: 07/12/2020] [Accepted: 07/19/2020] [Indexed: 02/08/2023] Open
Abstract
Introduction
The elderly population is the group most threatened by COVID-19, with the highest mortality rates. This study aims to analyse the case fatality of COVID-19 in a cohort of patients with degenerative dementia.
Methods
We conducted a descriptive case-control study of a sample of patients diagnosed with primary neurodegenerative dementia.
Results
Twenty-four of the 88 patients with COVID-19 included in the study died: 10/23 (43.4%) patients diagnosed with dementia and 14/65 (21.5%) controls; this difference was statistically significant.
Discussion
Our results suggest that case fatality of COVID-19 is significantly higher among patients with primary degenerative dementia than in other patients with similar mean ages and comorbidities.
Collapse